References
- Campell P M, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975; 4: 351–68
- Fries JF. The microvascular pathogenesis of scleroderma: an hypothesis. Ann Intern Med 1979; 91: 788–9
- Belch J JF. Raynaud's phenomenon, its relevance to scleroderma. Ann Rheum Dis 1991; 50: 839–45
- Follansbee W P, Curtiss E I, Medsger TA, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J. Med 1984; 310: 142–8
- Long A, Duffy G, Breshnian B. Reversible myocardial perfusion defects during cold challenge in scleroderma. Br J Rheumatol 1986; 25: 158–61
- Alexander E L, Fierstein G S, Weiss JL, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986; 105: 661–8
- Kahan A, Devaux J Y, Amor B, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986; 314: 1397–402
- D'Angelo W A, Fries J A, Masi A T, Schulman LE. Pathologic observation in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J. Med 1969; 46: 428–40
- Bulkley B H, Ridolfi R L, Salyer W R, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976; 53: 483–90
- Ferri C, Bernini L, Bongiorni MG, et al. Noninvasive evaluation of cardiac dysrhythmias and their relationship with multisystemic symptoms. in progressive systemic sclerosis patients. Arthritis Rheum 1985; 28: 1259–66
- Geirsson A J, Blom-Bülow B, Pahlm O, Åkeson A. Cardiac involvement in systemic sclerosis. Semin Arthritis Rheum 1989; 19: 110–6
- Botstein G R, LeRoy CE. Primary heart disease in systemic sclerosis (scleroderma): Advances in clinical and pathological features, pathogenesis, and new therapeutic approches. Am Heart J 1981; 102: 913–9
- Reichenbach D D, Benditt EP. Myofibrillar degeneration-a responce of the myocardial cell to injury. Arch Pathol Lab Med 1968; 85: 189
- Follansbee W P, Zerbe T R, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association. Am Heart J 1993; 125: 194–203
- Maione S, Valentini G, Giunta A, et al. Evaluation of cardiac structures and function in systemic sclerosis by doppler echocardiography. Cardiology 1991; 79: 165–71
- Kazzam E, Caidahl K, Hsugren R, et al. Non-invasive assessment of systolic function in systemic sclerosis. Eur Heart J 1991; 12: 151–6
- Hegedüs I, Czirák L. Left ventricular wall thickness and disease duration in systemic sclerosis. Postgrad Med J 1993; 69: 285–90
- Kazzam E, Waldenström A, Landelius J, et al. Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis. J Intern Med 1990; 228: 183–92
- Kahan A, Devaux J Y, Amor B, et al. Nicardipine improves myocardial perfusion in systemic sclerosis. J Rheumatol 1988; 15: 1395–400
- Kahan A, Devaux J Y, Amor B, et al. Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis. J Cardiovasc Pharmacol 1990; 15: 249–53
- Duboc D, Kahan A, Maziere B, et al. The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. Arthritis Rheum 1991; 34: 198–203
- Kazzam E, Caidahl K, Hällgren R, Gustafsson R, Waldenström A. Non-invasive evaluation of long-term effects of captopril in systemic sclerosis. J Intern Med 1991; 230: 203–12